Navigation

2003/019 NICE extends range of advice for people with cancer

The National Institute for Clinical Excellence has issued guidance on the use of drugs to treat both breast and bowel cancer. The guidance, on the use of capecitabine for breast cancer and capecitabine and tegafur with uracil for bowel cancer, is the latest in a series of recommendations on the use of cancer drugs made by the Institute. Since its establishment in April 1999 NICE has issued guidance on the use of 16 different drugs covering 9 types of cancer.

This page was last updated: 30 April 2009

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.